Chu P. Xie
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Author Correction: A broadly protective antibody targeting gammaherpesvirus gB.
Journal: Nature
Published: June 09, 2026
Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein-Barr Virus.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 13, 2025
A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virus.
Journal: Science China. Life sciences
Published: April 04, 2025
Structure and Antigenicity of Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein B.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 06, 2025
Applications of Artificial Intelligence in Biotech Drug Discovery and Product Development.
Journal: MedComm
Published: December 10, 2024
Unraveling coronavirus cell invasion: The role of glycan receptors in human coronavirus-HKU1 cell entry.
Journal: Infectious diseases & immunity
Published: September 11, 2024
Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization.
Journal: Cell reports
Published: August 25, 2024
Enhancing immune defense against COVID-19: Alveolar delivery of mucosal vaccines.
Journal: Science bulletin
Published: August 12, 2024
Desmocollin 2 is a dominant entry receptor for Epstein-Barr virus infection of epithelial cells.
Journal: Nature microbiology
Published: August 07, 2024
Research landmarks on the 60th anniversary of Epstein-Barr virus.
Journal: Science China. Life sciences
Published: July 22, 2024
Last Updated: 09/26/2026